DIGI 2.0
Project Objectives
Project Digi 2.0 aims to develop the Proof of Concept into a Prototype, the Global Pharma Tracker (GPT), by incorporating data from real shipments for a selected trade lane and expanding the platform capabilities.
Project Purpose
Digi 2.0 was created after the project Digi 1.0 concluded that building a common digital data sharing platform that integrates data from different and multiple sources is critical to achieve greater transparency to the pharma supply chain stakeholders.
Project Status And Key-takeaways
This project was finalized in December 2019. Digi 2.0 was divided into 4 work packages:
- Work Package 1: Technical implementation
- Work Package 2: Pilot onboarding
- Work Package 3: Business Value drivers
- Work Package 4: System Validation
The GPT was presented and demonstrated to the Pharma.Aero User Board and key departments in major pharmaceuticals shippers such as Pfizer, MSD and Johnson & Johnson, which acknowledged that the GPT is a value-adding tool to their supply chain management. Shipment data (e.g. milestones and activity duration, temperature events etc.) made available in a data warehouse format allows shippers to perform analysis. With AI and machine learning, more fine-grained predictive and prescriptive decision-making on a trade lane could be achieved. Read more details in the White Paper.
PROJECT
SUPPORT AND
COLLABORATION.
Pharma.Aero & Smart Freight Center
- Project leads: Brussels Airport Company, Changi Airport Group, Pfizer
- Project members: Mumbai Airport, Singapore Airlines, DHL Global Forwarding, AirBridgeCargo, Amerijet, EuroAirport, Hong Kong International Airport, Johnson & Johnson, Kansai International Airport, MSD, MVD Free Airport (now LACC), Sharjah Airport
- Project external support: Brussels Airlines, Nallian
- Project manager and expert: Hilde Havermans, Frank Van Gelder (external consultants)